“Patient response to revumenib has been good in other clinical trials,” explains Cuglievan. “But it’s also been short-lived when used...

There’s new evidence that Larotrectinib (Vitrakvi), by Loxo Oncology and Bayer, is highly effective in children with newly diagnosed...

The survival rate for children with a rare but deadly cancer could one day be improved by adding an existing drug—which is currently used...

Ewing’s sarcoma, osteosarcoma, and other bone cancers often impinge upon the growth plates of children’s arms and legs, explained...

Treatment with bicistronic CD19/CD22 CAR-T cell therapy has shown event-free survival improvements in children with relapsed or...

Early study results were so promising that the trial closed early, with findings published in the New England Journal of Medicine ...

Children with cancer died at home less often than adults, according to study results. Children with racial or ethnic minority backgrounds...

A new research program at Children’s Hospital of Philadelphia will focus exclusively on the long-term effects of cancer treatment in...

Though almost all childhood cancer survivors experience some epigenetic age acceleration, the experience is not the same across the whole...

Findings from scientists at St. Jude Children's Research Hospital are showing promise for assessing cardiomyopathy risk in childhood...